Written information about individual medicines for consumers

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Nicolson, Donald ^a   Knapp, Peter ^a   Raynor, D K ^a   Spoor, Pat ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ATORVASTATIN; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DICLOFENAC; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; GLYCERYL TRINITRATE; IBUPROFEN; INDOMETACIN; KETOPROFEN; LOOP DIURETIC AGENT; METHYLDOPA; NABUMETONE; NAPROXEN; NIFEDIPINE; NITRATE; NON PRESCRIPTION DRUG; PENICILLIN G; POTASSIUM; SIMVASTATIN; SPIRONOLACTONE; TERFENADINE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

BEHAVIOR; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONSUMER; CONTROL GROUP; DRUG INFORMATION; EMBASE; HOSPITAL PATIENT; HUMAN; INTERNET; KNOWLEDGE; MEDICAL INFORMATION; MEDLINE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT ATTITUDE; PHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PSYCINFO; REVIEW;

EID: 70349131209     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002104.pub3     Document Type: Review

References (202)

1. Arthur V, Clifford C. Evaluation of information given to rheumatology patients using non-steroid anti-inflammatory drugs. Journal of Clinical Nursing 1998;7:175-181 (Pubitemid 128705051)
2. Baker D, Roberts DE, Newcombe RG, Fox KA. Evaluation of drug information for cardiology patients. British Journal of Clinical Pharmacology 1991;31:525-531
3. Bergus GR, Levin IP, Elstein AS. Presenting risks and benefits to patients: the effect of information giving on decision making. Journal of General Internal Medicine 2002;17:612-617
4. Clark CM, Bayley EW. Evaluation of the use of programmed instruction for patients maintained on Warfarin therapy. American Journal of Public Health 1972;62:1135-1139
5. Desponds G, van MG, Schelling JL. Comparison of patient-oriented package insert for benzodiazepines [Etude comparative d'une nouvelle notice d'emballage pour benzodiazapines adaptee sux malades]. Schweizerische Medizinische Wochenschrift 1982;112:1376-1382
6. Dodds LJ. Effects of information leaflets on compliance with antibiotic therapy. Pharmaceutical Journal 1986;236:48-51.
7. Dolinsky D, Gross SM, Deutsch T, Demestihas E, Dolinsky R. Application of psychological principles to the design of written patient information. American Journal of Hospital Pharmacy 1983;40:266-271 (Pubitemid 13186752)
8. Gibbs S, Waters WE, George CF. The benefits of prescription information leaflets (1). British Journal of Clinical Pharmacology 1989;27:723-739
9. Johnson MW, Mitch WE, Sherwood J, Lopes L, Schmidt A, Hartley H. The impact of a drug information sheet on the understanding and attitude of patients about drugs. JAMA 1986;256:2722-2724 (Pubitemid 17178090)
10. Knapp P, Raynor DK, Berry DC. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Quality and Safety in Health Care 2004;13:176-180 (Pubitemid 38797502)
11. Kumana CR, Ma JT, Kung A, Kou M, Lauder I. An assessment of drug information sheets for diabetic patients: only active involvement by patients is helpful. Diabetes Research and Clinical Practice 1988;5:225-231 (Pubitemid 18229451)
12. Labor SL, Schommer JC, Pathak DS. Information overload with written prescription drug information. Drug Information Journal 1995;29:1317-1328
13. Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. BMJ 1998;316:1948-1952 (Pubitemid 28287144)
14. McBean BJ, Blackburn JL. An evaluation of four methods of pharmacist- conducted patient education. Canadian Pharmaceutical Journal 1982;115:167-172
15. Morris LA, Kanouse DE. Informing patients about drug side effects. Journal of Behavioral Medicine 1982;5:362-373
16. Peura S, Klaukka T, Hannula AM, Eerikainen S. Electronically produced information leaflets increase patients' understanding of antibiotics. International Journal of Pharmacy Practice 1993;2:22-25
17. Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999;319:612-615 (Pubitemid 29414560)
18. Pope JE, Stevens A, Rooks M. A randomized double blind trial of verbal NSAID education compared to verbal and written education. Journal of Rheumatology 1998;25:771-775 (Pubitemid 28212390)
19. Regner MJ, Hermann F, Ried LD. Effectiveness of a printed leaflet for enabling patients to use digoxin side-effect information. Drug Intelligence and Clinical Pharmacy 1987;21:200-204 (Pubitemid 17009382)
20. Robinson GL, Gilbertson AD, Litwack L. The effects of a psychiatric patient education to medication program on post-discharge compliance. The Psychiatric Quarterly. 1986;58:113-118 (Pubitemid 17032437)
21. Savas S, Evcik D. Do undereducated patients read and understand written education materials? A pilot study in Isparta, Turkey. Scandinavian Journal of Rheumatology 2001;30:99-102. (Pubitemid 32250799)
22. Strydom A, Hall I. Randomized trial of psychotropic medication information leaflets for people with intellectual disability. Journal of Intellectual Disability Research 2001;45:146-151 (Pubitemid 32303368)
23. van Haecht CHM, Vander Stichele R, Debacker G, Bogaert MG. Impact of patient package inserts on patients' satisfaction, adverse drug-reactions and risk perception - the case of NSAIDs for posttraumatic pain relief. Patient Education and Counseling 1991;17:205-215
24. Vander Stichele RH, Vandierendonck A, De Vooght G, Reynvoet B, Lammertyn J. Impact of benefit messages in patient package inserts on subjective drug perception. Drug Information Journal 2002;36:201-208 (Pubitemid 34208218)
25. Vesco D, Toumi M, Faraj F, Razzouk H, Orehek J. Manufacturer's information insert and subjective theophylline side-effects. European Respiratory Journal 1990;3:1162-1165
26. Angunawela I, Mullee MA. Drug information for the mentally ill: A randomized controlled trial. International Journal of Psychiatry in Clinical Practice 1998;2:121-127 (Pubitemid 28313961)
27. Al-Eidan FA, McElnay JC, Scott MG, McConnell JB. Management of Helicobacter pylori eradication-the influence of structured counselling and follow-up. British Journal of Clinical Pharmacology 2002;53:163-171
28. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. British Journal of Clinical Pharmacology 2002;54:657-664 (Pubitemid 36002595)
29. Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: Open randomised controlled trial in a psychiatric hospital in Kuwait. International Journal of Pharmacy Practice 2005;13:123-131 (Pubitemid 40799564)
30. Anonymous. It's on paper, but do they understand it? Simple testing gets written handouts on target. Patient Education Management 1999;6:8-12.
31. Ascione FJ, Shimp LA. The effectiveness of four education strategies in the elderly. Drug Intelligence and Clinical Pharmacy. 1984;18:926-931
32. Atherton-Naji A, Hamilton R, Riddle W, Naji S. Improving adherence to antidepressant drug treatment in primary care: A feasibility study for a randomized controlled trial of education intervention. Primary Care Psychiatry 2005;7:61-67 (Pubitemid 32725311)
33. Azrin NH, Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behaviour Research and Therapy 1998;36:849-861 (Pubitemid 28377132)
34. Barlow JH, Pennington DC, Bishop PE. Patient education leaflets for people with rheumatoid arthritis: A controlled study. Psychology Health and Medicine 1997;2:221-235 (Pubitemid 27464162)
35. Bernardini C, Ambrogi V, Perioli L, Tiralti MC, Fardella G. Comprehensibility of the package leaflets of all medicinal products for human use: a questionnaire survey about the use of symbols and pictograms. Pharmacological Research 2000;41(6):679-688 (Pubitemid 30671834)
36. Bernardini C, Ambrogi V, Fardella G, Perioli L, Grandolini G. How to improve the readability of the patient package leaflet: A survey on the use of colour, print size and layout. Pharmacological Research 2001;43:437-443 (Pubitemid 32578859)
37. Berry SH, Kanouse DE, Hayes-Roth B, Rogers WH, Winkler JD, Garfinkle JB. Informing Patients About Drugs: Analysis of Alternative Designs for Flurazepam Leaflets. RAND Corporation, 1981.
38. Berry DC, Raynor DK, Knapp P, Bersellini E. Official warnings on thromboembolism risk with oral contraceptives fail to inform users adequately. Contraception 2002;66:305-307 (Pubitemid 35346602)
39. Berry DC, Holden W, Bersellini E. Interpretation of recommended risk terms: Differences between doctors and lay people. International Journal of Pharmacy Practice 2004;12:117-124 (Pubitemid 39287187)
40. Berto D, Peroni M, Milleri S, Spagnolo AG. Evaluation of the readability of information sheets for healthy volunteers in phase-I trials. European Journal of Clinical Pharmacology 2000;56:371-374 (Pubitemid 30666062)
41. Bjorck Linne A, Liedholm H, Jacobsson L. The effects on knowledge of the systematic education of patients with joint diseases treated with NSAIDs and diuretics. Patient Education and Counseling 2001;42:165-174
42. Chin-Quee D, Wong E, Cuthbertson C. Evaluating information on oral contraceptive use: A randomized controlled trial to assessmissed pill instructions. Human Reproduction 2006;21:3137-3145 (Pubitemid 44811616)
43. Clementsen PS, Kristensen KS, Kamp-Jensen M, Kampmann JP. Patients' knowledge about their own medication - does verbal information help? [Patienters viden om egen medicin - hjælper mundtlig information?]. Ugeskrift for Laeger 1992;154:2264-2266
44. Clinite JC, Kabat HF. Improving patient compliance. Journal of the American Pharmaceutical Association 1976;16:74-76
45. Crawford P, Hudson S. Understanding the information needs of women with epilepsy at different lifestages: Results of the 'Ideal World' survey. Seizure 2003;12(7):502-507
46. Crichton EF, Smith DL, Demanuele F. Patient recall of medication information. Drug Intelligence & Clinical Pharmacy 1987;10:591-599
47. Crilly M, Esmail A. Randomised controlled trial of a hypothyroid educational booklet to improve thyroxine adherence. British Journal of General Practice 2005;55:362-368 (Pubitemid 40585210)
48. Culbertson VL, Arthur GT, Rhodes PJ, Rhodes RS. Consumer preferences for verbal and written medication information. Drug Intelligence and Clinical Pharmacy 1988;22:390-396
49. Demiralay R. Comparison of the effects of three forms of individualized education on asthma knowledge in asthmatic patients. Turkish Journal of Medical Sciences 2002;32:57-64. (Pubitemid 34168884)
50. Demiralay R. The effects of asthma education on knowledge, behaviour andmorbidity in asthmatic patients. Turkish Journal of Medical Sciences 2004;34:319-326 (Pubitemid 39572310)
51. Discenza R, Ferguson JM. The instrumental role of product information: a study of warning labels for non-prescription drugs. Health Marketing Quarterly 1992;10:155-168
52. Eaton ML, Holloway RL. Patient comprehension of written drug information. American Journal of Hospital Pharmacy 1980;37:240-243
53. Edworthy SM, Devins GM. Improving medication adherence through patient education distinguishing between appropriate and inappropriate utilization. Journal of Rheumatology 1999;8:1793-1801.
54. Esposito L. The effects of medication education on adherence to medication regimens in an elderly population. Journal of Advanced Nursing 1995;21:935-943
55. Evans M, Macpherson R, Thompson E, Babiker I. Educating psychiatric patients about their treatment: do fact sheets work?. Journal of the Royal Society of Medicine 1996;89:690-693 (Pubitemid 27026244)
56. Ferguson JM, Discenza R, Miller JA. Increasing the odds of patient compliance through prescription warning labels. Journal of Health Care Marketing 1987;7:37-46.
57. Fincham JE. The use of specialized patient medication information sheets with end stage renal disease patients: a pilot study. Patient Education and Counseling 1995;7:43-51.
58. Gardner M, Hurd PD, Slack M. Effect of information organization on recall of medication instructions. Journal of Clinical Pharmacy and Therapeutics 1990;15:13-19
59. Halperin JA. Useful patient information on prescription drugs. Annals of Pharmacotherapy 1998;32:612. (Pubitemid 28232772)
60. Hannes E. Adverse drug effects and the need for drug information. Medical Care 1991;29:558-564.
61. Hartzema AG, Day RS, Tolleson-Rinehart S, Sleath B, Bush PJ. Optimizing Patient Comprehension Through Medicine Information Leaflets A Final Report. Report issued by United States Pharmacopeia, 1999.
62. Harvey JL, Plumridge RJ. Comparative attitudes to verbal and written medication information among hospital outpatients. The Annals of Pharmacotherapy 1991;25:925-928
63. Hayes KS. Randomized trial of geragogy-based medication instruction in the emergency department. Nursing Research 1996;47:211-218
64. Hendler K, Donchin Y, Brezis M, Waisman Y. Do patients recall and understand communicated information upon discharge fromthe emergency department? (multiple letters). Israel Medical Association Journal 2003;5(11):838. (Pubitemid 37441389)
65. Hill J. The effect of patient education on adherence with drug therapy, outcome and satisfaction in patients with RA (BL). PhD, University of Leeds, UK 2000.
66. Hill J, Bird H. The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis. Rheumatology 2003;42:66-70. (Pubitemid 36131569)
67. Holcomb CA. The cloze procedure and readability of patient-oriented drug information. Journal of Drug Education 2003;13:347-357
68. Hussain SA, George E, Kennedy TD. A comparison of patient information sheets for methotrexate. Rheumatology 2003;42:194-195 (Pubitemid 36131594)
69. Hämeen-Anttila K, Kemppainen K, Enlund H, Bush Patricia J, Marja A. Do pictograms improve children's understanding of medicine leaflet information?. Patient Education and Counseling. 2004;55:371-378 (Pubitemid 39593161)
70. Jacobs JY, Gallelli JF. Evaluation of antineoplastic drug package inserts from different countries. Annals of Pharmacotherapy 1996;12:1496-1498
71. Jones R, Finlay F, Crouch V, Anderson S. Drug information leaflets: adolescent and professional perspectives. Child: Care, Health & Development 2000;26:41-48
72. Kelloway JS, Kochevar JW, Sveum RJ, Hahn MA. Evaluation of the Autohaler actuator: the effect of written patient instructions on correct use. Journal of Asthma 1993;30:373-379
73. Kirksey O, Harper K, Thompson S, Pringle M. Assessment of Selected Patient Educational Materials of Various Chain Pharmacies. Journal of Health Communication 2004;9:91-93 (Pubitemid 38507297)
74. Kirscht JP, Kirscht JL, Rosenstock IM. A test of interventions to increase adherence to hypertensive medical regimens. Health Education Quarterly 1981;8:261-272
75. Knapp P, Raynor DK, Jebar AH, Price SJ. Interpretation of medication pictograms by adults in the UK. Annals of Pharmacotherapy 2005;39:1227-1233
76. Krass I, Svarstad BL, Bultman D. Using alternative methodologies for evaluating patient medication leaflets. Patient Education and Counseling 2002;47:29-35. (Pubitemid 34522084)
77. Laher M, O'Malley K, O'Brien E, O'Hanrahan M, O'Boyle C. Educational value of printed information for patients with hypertension. British Medical Journal (Clinical Research ed) 1981;282:1360-1361 (Pubitemid 11057054)
78. Lamb GC, Green SS, Heron J. Can physicians warn patients of potential side effects without fear of causing those side effects?. Archives of International Medicine 1994;154:2753-2756 (Pubitemid 24378447)
79. Leal Hernández M, Abellán Alemán J, Martínez Crespo J, Nicolás Bastida A. Written information on the use of aerosols in COPD patients. Can we improve their use?. Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2004;33(1):6-10. (Pubitemid 38374436)
80. Ley P, Jain VK, Skilbeck CE. A method for decreasing patients' medication errors. Psychological Medicine 1976;6:599-601.
81. Lirsac B, Braunstein G. Randomized evaluation of two teaching methods using aerosol dosers. Revue des Maladies Respiratoires 1991;8:559-565
82. Little P, Rumsby K, Kelly J, Watson, L. Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA 2005;293:3029-3035 (Pubitemid 40965073)
83. Macfarlane JT, Holmes WF, Macfarlane, RM. Reducing reconsultations for acute lower respiratory tract illness with an information leaflet: A randomized controlled study of patients in primary care. British Journal of General Practice 1997;47:719-722
84. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. British Medical Journal (Clinical Research ed.) 2002;324:91-94 (Pubitemid 34073141)
85. Madoff SA, Pristach CA, Smith CM, Pristach EA. Computerized medication instruction for psychiatric inpatients admitted for acute care. MD Computing 1996;13:427-431
86. Mainous AG, Hueston WJ, Love MM, Evans ME, Finger R. An evaluation of statewide strategies to reduce antibiotic overuse. Family Medicine 2000;32:22-29 (Pubitemid 30036471)
87. Mansoor LE, Dowse R. Effect of pictograms on readability of patient information materials. Annals of Pharmacotherapy 2003;37:1003-1009 (Pubitemid 36875229)
88. Mansoor LE, Dowse R. Medicines information and adherence in HIV/AIDS patients. Journal of Clinical Pharmacy and Therapeutics 2006;31:7-15.
89. Mansoor L, Dowse R. Written medicines information for South African HIV/AIDS patients: Does it enhance understanding of cotrimoxazole therapy?. Health Education Research 2007;22:37-48. (Pubitemid 46134974)
90. McCormack JP, Dolovich L, Levine M, Burns S, Nair K. Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?. Health Expectations 2003;6:281-289 (Pubitemid 37484461)
91. Miquel AV Ortín Font F, Marrugat J, Pavesi M. Assessment of the comprehension of new rephrasing drug package inserts. Medicina Clinica 2000;115:410-417 (Pubitemid 32047526)
92. Morris LA, Tabak ER, Gondek K. Counseling patients about prescribed medication: 12-year trends. Medical Care 1997;35:996-1007.
93. Morrow DG, Hier CM, Menard WE, Leirer Von O. Icons improve older and younger adults' comprehension of medication information. Journals of Gerontology: Series B: Psychological Sciences and Social Sciences 1998;53B:240-254
94. Mundt JC, Clarke GN, Burroughs D, Brenneman DO, Griest JH. Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education. Depression and Anxiety 2001;13:1-10. (Pubitemid 32537088)
95. Murphy DA, Lu MC, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. Journal of the Association of Nurses in AIDS Care 2002;13:57-69.
96. Myers ED, Calvert EJ. Information, compliance and side-effects: A study of patients on antidepressant medication. British Journal of Clinical Pharmacology 1984;17:21-25 (Pubitemid 14054605)
97. Myers RE, Shepard-White F. Evaluation of Adequacy of Reading Level and Readability of Psychotropic Medication Handouts. Journal of the American Psychiatric Nurses Association 2004;10:55-59 (Pubitemid 39149376)
98. Neafsey PJ, Strickler Z, Shellman J, Chartier V. An interactive technology approach to educate older adults about drug interactions arising from over-the-counter self-medication practices. Public Health Nursing 2002;19:255-262
99. Ngoh LN. The comprehension of antibiotic prescription instructions and their utilization in three primary health care settings in Cameroon, West Africa. Doctoral Dissertation, University of Texas at Austin 1992.
100. Ngoh LN, Shepherd MD. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon.. Patient Education and Counseling 1997;30:257-270 (Pubitemid 27104522)
101. Norell SE. Improving medication compliance: a randomised clinical trial. British Medical Journal 1979;2:1031-1033 (Pubitemid 10249394)
102. O'Connell C. Patient information leaflets for prescription drugs: A comparative consumer acceptability study. PhD: Temple University 1995.
103. Oldman M, Moore D, Collins S. Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction. British Journal of Anaesthesia 2004;92:854-858 (Pubitemid 38771688)
104. Pander Maat H, Klaassen R. The effect of the wording of information about side effects on patients' interpretation of reported side effects [De invloed van de formulering van informatie over bijwerkingen op interpretaties door patienten en op gemelde bijwerkingen]. Nederlands Tijdschrift voor Geneeskunde 1996;140:424-427
105. Quaid K.A, Faden RR, Vining EP, Freeman JM. Informed consent for a prescription drug: impact of disclosed information on patient understanding and medical outcomes. Patient Education and Counseling 1990;15:249-259
106. Rabol R, Engelbrecht Andreasen AG, Kampmann JP, Christensen HR. Written drug information: Do patients benefit?. Ugeskrift for Laeger 2002;164:2509-2513. (Pubitemid 34495559)
107. Rollins BL, Sullivan DL. Evaluating consumer understanding of two patient instructions for use inserts provided by manufacturers. Drug Information Journal 2005;39:43-51.
108. Ronmark E, Jogi R, Lindqvist A, Haugen T, Meren M, Loit HM, et al. Correct use of three powder inhalers: Comparison between diskus, turbuhaler, and easyhaler. Journal of Asthma 2005;42:173-178 (Pubitemid 40776961)
109. Ruck BE, Hatton RC, Doering PL. Comparison of two self-instructional manuals on adverse drug reaction monitoring. American Journal of Hospital Pharmacy 1990;47:2062-2064 (Pubitemid 20326461)
110. Russell WL, Roberts RW, Bradley DL, Marshall JC, Glazer-Waldman H. Patient package inserts: a study of communication techniques. Contemporary Pharmacy Practice 1979;2:56-61.
111. Sands CD, Robinson JD, Orlando JB. The oral contraceptive PPI: its effect on patient knowledge, feelings, and behavior... patient package insert. Drug Intelligence and Clinical Pharmacy 1984;18:730-735
112. Sansgiry SS, Cady PS, Sansgiry S. Consumer involvement: effects on information processing from over-the-counter medication labels. Health Marketing Quarterly 2001;19:61-78.
113. Satterwhite BA, Pryor AS, Harris MB. Development and evaluation of chemotherapy fact sheets. Cancer Nursing 1980;3:277-283
114. Saunders LD, Irwig LM, Gear JS, Ramushu DL. A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Medical Care 1991;7:669-678
115. Savage I, Goodyear L. Providing information onmetered dose inhaler technique: is multimedia as effective as print?. Family Practice 2003;20:552-557 (Pubitemid 37258759)
116. Schaffer SD, Tian L. Promoting Adherence: Effects of Theory-Based Asthma Education. Clinical Nursing Research 2004;1:69-89.
117. Segador J, Gil-Guillen VF, Orozco D, Quirce F, Carratala MC, Fernandez- Parker A, Merino J. The effect of written information on adherence to antibiotic treatment in acute sore throat. International Journal of Antimicrobial Agents 2005;26:56-61. (Pubitemid 40854117)
118. Smith NA, Seale JP, Ley P, Shaw J, Bracs PU. Effects of intervention on medication compliance in children with asthma. The Medical Journal of Australia 1986;144:119-122 (Pubitemid 16084434)
119. Smith LF, Whitfield MJ. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice. British Journal of General Practice 1995;45:409-414
120. Smith H, Gooding S, Brown R, Frew A. Information in practice. Evaluation of readability and accuracy of information leaflets in general practice for patients with asthma. BMJ 1998;317:264-265 (Pubitemid 28334156)
121. Stratton TP, Barreuther A, Schondelmeyer SW. Comparison of consumer- oriented books on medications. Patient Education and Counseling 1984;5:107-117
122. Sukkari SR, Sasich LD, Arnott W, Muller P, Peterson RG. Cisapride and patient information leaflets. Canadian Medical Association Journal 2001;164:1276-1279
123. Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. Journal of the Medical Association of Thailand 2005;88:s131-41.
124. Swanson JM, Forrest K, Ledbetter C, Hall S, Holstine EJ, Shafer MR. Readability of commercial and generic contraceptive instructions. Image: Journal of Nursing Scholarship 1990;22:96-100.
125. Sweileh WM, Zeid A-A-N, Jaradat NA. Drug informational value of patient package insert (PPI): A sample study in palestine. Natural Sciences Series 2004;12:59-68.
126. Temple B. A marriage of convenience? Combining methods of research on advice giving for over-the-counter medication. Health Care Analysis 1997;5:168-171
127. Thomas SG, Diethelm AG, Keith TD, Simmons SM. Evaluating the quality of patient education in a self-medication teaching program. Hospital Formulary 1983;18:871-874
128. Thomas LG, Corwin EJ. Marketing and management. The readability of printed education materials regarding hormone replacement therapy. Journal of the American Academy of Nurse Practitioners 1998;10:447-452
129. Thompson DF, Vance D, Callard JC, Thompson Jr CM. Accessing the lay drug literature: A comparison of Dialog, BRS, and Wilsonline. Drug Information Journal 1988;22:531-538 (Pubitemid 19026205)
130. Trollor J. A drug information system. The patients' responses.. Australian Family Physician 1989;18:28-30.
131. Tymchuk AJ. Readability levels of over-the-counter medications commonly used by elderly people: A possible issue in compliance. Educational Gerontology 1990;16:491-496
132. Udkow GP, Lasagna L, Weintraub M, Tamoshunas Z. The safety and efficacy of the estrogen patient package insert. A questionnaire study. Journal of the American Medical Association 1979;242:536-539 (Pubitemid 9237569)
133. van Haecht CH, Vander Stichele R, Bogaert MG. Package inserts for antihypertensive drugs: use by the patients and impact on adverse drug reactions. European Journal of Clinical Pharmacology 1990;39:551-554
134. Vivian AS, Robertson EJ. Readability of Patient Education Materials. Clinical Therapeutics 1980;3:129-136
135. Webb LH, Shewan J, Adebajo AO, Harker SD. An evaluation of two rheumatology patient information programs. Rheumatology 2001;40:418-419 (Pubitemid 34065373)
136. Webber D, Higgins L, Baker V. Enhancing recall of information from a patient education booklet: A trial using cardiomyopathy patients. Patient Education and Counseling 2001;44:263-270 (Pubitemid 32842867)
137. Whatley S, Mamdani M, Upshur REG. A randomised comparison of the effect of three patient information leaflet models on older patients' treatment intentions. The British Journal of General Practice 2002;52:483-484 (Pubitemid 34578187)
138. Whiteside SE, Harris A, Whiteside HD. Patient education: effectiveness of medication programs for psychiatric patients. Journal of Psychosocial Nursing and Mental Health Services 1983;21:16-21.
139. Winkler JD, Kanouse DE, Berry SH, Hayes-Roth B, Rogers WH, Garfinkle JB. Informing Patients About Drugs: Analysis of Alternative Designs for Erythromycin Leaflets. RAND Corporation, 1981.
140. Wise PH, Dowlatshahi DC, Farrant S, Fromson S, Meadows KA. Effect of computer-based learning on diabetes knowledge and control. Diabetes Care 1986;9:504-508 (Pubitemid 16008980)
141. Wissmann C. Drug information cards for cancer patients. American Journal of Hospital Pharmacy 1989;46:70.
142. Worsley A. Perceived reliability of sources of health information. Health Education Research 1989;4:367-376 (Pubitemid 19252338)
143. Young HN, Bell RA, Epstein RM, Feldman MD, Kravitz RL. Types of information physicians provide when prescribing antidepressants. Journal of General Internal Medicine 2006;21:1172-1177
144. Young SD, Oppenheimer DM. Different methods of presenting risk information and their influence on medication compliance intentions: Results of three studies. Clinical Therapeutics 2006;28:129-139
145. Zion AB, Aiman J. Level of reading difficulty in The American College of Obstetricians and Gynecologsts Patient Education pamphlets. Obstetrics & Gynecology 1989;74:955-960 (Pubitemid 20003294)
146. Zondag CHJ, Blom ATG, Broekama WJ, Leemans L, Martens EP, Schobben AFAM. Introduction and effect. Drug information on a psychiatry ward [Geneesmiddeleninformatie op een psychiatrische afdeling : De introductie en het effect]. Pharmaceutisch Weekblad 2002;137:390-392
147. Zweifler AJ, Kaunisto CA. Education of the hypertensive patient: the Ann Arbor approach. Journal of Hypertension 1989;7:S89-91.
148. Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Education and Counseling 2007;67:157-168 (Pubitemid 46880130)
149. Gundogar D, Demirci S, Uluhan F. How should we inform patients about antidepressants? A study comparing verbal and written information. International Journal of Pharmacy Practice 2007;11:212-217 (Pubitemid 47450818)
150. McDonald DD, Amendola MG, Interlandi E, Wall K, Lewchik B, Polouse L, et al. Effect of reading additional safety information on planned use of over-the-counter analgesics. Public Health Nursing 2007;24:230-238
151. Ziklund-Fisher BJ, Fagerlin A, Roberts TR, Derby HA, Ubel PA. Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrence. Journal of Health Communication 2008;13:107-124 (Pubitemid 351304461)
152. Arthur VAM. Written patient information: a review of the literature. Journal of Advanced Nursing 1995;21:1081-1086
153. Aslani P. Consumer medicines information. PhD. University of Sydney 2000.
154. Bellantuono C, Reggi V, Tognoni G, Garatini S. Benzodiazepines: clinical pharmacology and therapeutic use. Drugs 1980;19:195-219. (Pubitemid 10095772)
155. Berry DC, Knapp P, Raynor DK. Provision of information about drug side effects to patients. Lancet 2002;359:853-854 (Pubitemid 34233761)
156. Buck M. Providing patients with written medication information. Annals of Pharmacotherapy 1998;32:962-969 (Pubitemid 28420335)
157. Campbell P, Cobb A, Darton K. Psychiatric Drugs, Users' Experiences and Current Policy and Practice. London: MIND publications 1998.
158. 104th Congress. Public Law 104-180. http://frwebgate.access.gpo.gov/cgi- bin/getdoc.cgi?dbname=104-cong-public-laws&docid=f:publ180.104 (accessed 28 Oct 2008) 1996.
159. Consumers Association. Patient information: what's the prognosis?. London: Consumers Association 2003.
160. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough?. BMJ 1999;318:318-322 (Pubitemid 29195144)
161. Detmer DE, Singleton PD, MacLeod A, Wait S, Taylor M, Ridgwell J. The Informed Patient: Study Report. Cambridge: Cambridge University Health 2003.
162. Dickinson D, Raynor DK. Ask the patients-they may want to know more than you think. BMJ 2003;327:861. (Pubitemid 37271704)
163. Dixon-Woods M. Writing wrongs? An analysis of published discourses about the use of patient information leaflets. Social Science and Medicine 2001;52:1417-1432 (Pubitemid 32177782)
164. Donovan J, Blake D. Patient non-compliance:deviance or reasoned decision-making?. Social Science and Medicine 1992;35:507-513
165. European Commission. Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets. (OJ No. L 113 of 30.4.1992, p. 8).
166. European Commission, Directorate-General III. A guideline on the readability of the label and package leaflet of medicinal products for human use. Brussels: European Commission 1998.
167. European Commission. Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use. Official Journal L 311, 28/11/2001 2001:67-128.
168. European Commission. 383 in response to the report of the G10 Medicines Group. Brussels: European Commission 2003.
169. European Commission. Directive 2004/27/EC of the European parliament and of the council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating tomedicinal products for human use.. Official Journal L 136, 30/4/2004 2004:34-57.
170. Flesch RR. A new readability yardstick. Journal of Applied Psychology 1948;32:221-223
171. Forster A, Young J, Smith J, Knapp P, House A, Wright J. Information provision for stroke patients and their caregivers. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI:10.1002/14651858.CD001919]
172. George CF, Waters WE, Nicholas JA. Prescription information leaflets: a pilot study in general practice. British Medical Journal 1983;287:1193-1196
173. Gibbs S, Waters WE, George CF. The design of prescription information leaflets and feasibility of their use in general practice. Pharmaceutical Medicine 1987;2:23-34. (Pubitemid 17110381)
174. Greenblatt DJ, Shader RL. Dependence, tolerance and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Metabolism Reviews 1978;8:13-28.
175. Hartley J. Designing instructional text. London: Kogan Page, 1994.
176. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI:10.1002/14651858.CD000011.pub3]
177. Higgins JPT, Green S (Editors). Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd, Issue 4, 2006.
178. Juni P, Altman DG, Egger M. Assessing the quality of randomised controlled trials. In: Egger M, Davey Smith G, Altman D Geditor(s). Systematic Reviews in Health Care: Meta-analysis in Context. London: BMJ Books, 2001:87-107.
179. Kenny T, Wilson R, Purves I, Clark J, Newton L, Newton D, Moseley D. A PIL for every ill? Patient information leaflets: a review of past, present and future. Family Practice 1998;15:471-479 (Pubitemid 28519923)
180. Koo M, Krass I, Aslani P. Factors influencing consumer use of written drug information. Annals of Pharmacotherapy 2003;32:259-267 (Pubitemid 36172869)
181. Ley P. Communicating with patients. London: Croom Helm, 1988.
182. Littlewood S, Ypinazar V, Margolis SA, Scherpbier A, Spencer J, Dornan T. Early practical experience and the social responsiveness of clinical education: systematic review. BMJ 2005;331:387-391 (Pubitemid 41153189)
183. Lowe CJ, Raynor DK. Intentional non-adherence in the elderly: fact or fiction?. Pharmaceutical Journal 2000;265:R19.
184. Morris LA, Halperin JA. Effects of written drug information on patient knowledge and compliance. American Journal of Public Health 1979;69:47-52.
185. NHS. The NHS Plan. A plan for investment. A plan for reform. London: Stationery Office, 2000.
186. Nicolson DJ, Knapp P, Raynor DK, Grime J, Pollock K. Do themes in consumer medicines information literature reviews reflect those important to stakeholders?. Patient Education and Counseling 2006;64:112-118 (Pubitemid 44772948)
187. Nicolson DJ. Why we need to study websites that provide information about medicines. Pharmaceutical Journal 2007;279:124.
188. Nightingale SL. Written patient information on drugs. Journal of Technology Assessment and Health Care 1995;11:399-409.
189. Parker S. PILs down under - lessons for the UK. Pharmacy Business and Practice. London: NPA, 2001.
190. Raynor DK. The influence of written information on patient knowledge and adherence to treatment. Adherence to treatment in medical conditions. London: Harwood Academic, 1998.
191. Raynor DK. Consumer medicines information: an international perspective. The Chronic Ill. Journal of Malta College of Pharmacy Practice 2003;7:7-11.
192. Raynor DK, Savage I, Knapp P, Henley J. We are the experts. People with asthma talk about their medicine information needs. Patient Education and Counseling 2004;53:167-174 (Pubitemid 38622061)
193. Raynor DK, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK?. International Journal of Pharmacy Practice 2007;15:209-218
194. Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines.. Health Technology Assessment 2007;11:1-178. (Pubitemid 46470439)
195. Royal Pharmaceutical Society of Great Britain and Merck Sharp & Dohme. From compliance to concordance: achieving shared goals in medicine taking. London: RPS, 1997.
196. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
197. Sless D. Usable medicines information. CRIA: Canberra, 2001.
198. Steering committee for the collaborative development of a long-range action plan. Action plan for the provision of useful prescription medicine information. http://www.fda.gov/Cder/Offices/ODS/keystone.pdf (accessed 29 Oct 2008). US Department of Health and Human Services, 1996.
199. Strydom A, Forster M, Wikie BM, Edwards C, Hall IS. Medication information leaflets for people with learning disabilities who take psychiatricmedications. British Journal of Learning Disabilities 2001;29:1-5. (Pubitemid 33273443)
200. Svarstad BL, Bultman DC, Mount JK, Tabak ER. Evaluation of written prescription information provided in community pharmacies: a study in eight states. Journal of the American Pharmaceutical Association 2003;43(3):383-393 [DOI: 10.1331/154434503321831102]
201. van der Waarde K. An investigation into the suitability of the graphic presentation of patient package inserts. PhD. University of Reading 1993.
202. Wright P. Designing healthcare advice for the public. Handbook of Applied Cognition. Chichester: John Wiley, 1999.